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ABSTRACT 
 
Dengue fever disease has become common problem in developing countries including Indonesia. 
Mixture models are usually used in modelling data consisting of several groups, where each group 
has different properties and characteristics of the one family but uses the same distribution. Weibull 
mixture models have received increasing attention in recent statistical research with applications in 
the field of survival analysis. The advances in the Bayesian paradigm have substantially expanded the 
methodology and application of Weibull mixture models. One problem of current interests is the 
analysis of survival times of patients. Dengue hemorrhagic fever data can be used to make 
inference about patient survival. In this study, we focus on the use of Bayesian Weibull mixture 
models for estimating survival. A simulation study that investigates the impact of censoring on these 
models is also described.  
 
Keywords: Bayesian, Censoring, Dengue hemorrhagic fever, Mixtures, Survival analysis, Weibull 
distribution. 
1. INTRODUCTION 
 
 Indonesia is a tropical country with two seasons: rainy season and dry season. 
Tropical natural environment, poor sanitation, and lack of public awareness were the main 
reasons of the spread of dengue in Indonesia. Demographic and societal changes such as 
population growth, urbanization, and modern transportation appear to play an important role 
in the increased incidence and geographical spread of dengue virus (Gubler, 2002). Dengue 
Hemorrhagic Fever (DHF) in Indonesia is a disease caused by the bite of Aedes aegypti. If a 
person gets infected, this virus may result in her/his death (National Geographic Indonesia, 
2012). 
DHF usually affects children, but in recent decades it has been a trend of increases in 
the proportion of more mature age. Indonesia occupies the highest position in the case of 
DHF in Southeast Asia with 10,000 cases in 2011 (National Geographic Indonesia, 2012). 
Although, Makassar is categorized one of 10 regions ranked highest DHF (detikHealth, 
2012), efforts to prevent the spread of this disease and to reduce mortality needs to be done. 
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Government of Makassar sets 5 Sub districts of 14 districts in Makassar, as its prone areas to 
the spread of dengue disease (Viva news, 2013). 
Preventive Efforts to reduce mortality should be done, such as increasing awareness 
and a healthy way of life in order to prevent the occurrence and spread of dengue fever 
(Kautler et al., 1997). On the other hand, the reduction of the mortality rate can be r curative 
by providing appropriate medical therapy. On the latter, the issue of patients’ survival with 
DHF becomes very important to be studied. 
Survival time of patients can be affected by many factors. In addition, the survival of 
patients with DHF is largely determined by the ability to develop and implement appropriate 
methods to a) identify factors that influence survival and b) get a model based on those 
factors. One of the popular methods is proportional hazard regression Nguyen and Rocke, 
2002, Rosenwald et al., 2002, Kleinbaum dan Klein, 2005). This method only uses present 
data as a basis to estimate patient survival times and does not takes into account available 
prior information, other unknown features of the model or the model structure itself. In a 
Bayesian framework, such information can be informed through prior distributions and 
uncertainty in the model structure can be accommodated (Kaderali et al. 2006; Tachmazidou 
et al. 2008). Since the advances in computational and modeling technique, Bayesian methods 
are now becoming quite common for survival data (Kaderali et al., 2006; Lee dan Mallick, 
2004; Thamrin et al., 2012, Thamrin et al., 2013, Thamrin, 2013).  
Given the nature of DHF data to describe biological systems and outcomes of 
patients, and hence the potential of these covariates to produce more precise inferences about 
survival, the use of a single parametric distribution to describe survival time may not be 
adequate. DHF data may enable the description of several homogeneous subgroups of 
patients with respect to survival time. This research therefore used Bayesian Weibull mixture 
models for better estimation and prediction of this outcome, following the notion that the 
Weibull distribution is a popular parametric distribution for describing survival times 
(Dodson, 1994) and mixture models are commonly used in describing data consisting of 
several groups, where each group has different properties and features of the one family but 
uses the same distribution. These models provide a convenient and flexible mechanism to 
identify and estimate distributions, which are not well modelled by any standard parametric 
approaches (Stephens, 1997). There is developing literature on the application of Weibull 
mixture models in the field of survival and reliability analysis. The advances in EM algorithm 
Dempster et al. (1977), the Bayesian paradigm (Berger, 1985, Besag et al., 1995), and 
3 
 
Markov chain Monte Carlo (MCMC) computational methods (Diebolt and Robert, 1994) 
have substantially expanded the methodology and application of Weibull mixture models. In 
the Bayesian context, Marin et al. (2005a) described methods to fit aWeibull mixture model 
with an unknown number of components. Farcomeni and Nardi (2010) proposed a two 
component mixture to describe survival times after an invasive treatment. Quiang (1994) also 
used a mixture of a Weibull component and a surviving fraction in the context of a lung 
cancer clinical trial. Tsionas (2002) considered a finite mixture of Weibull distributions with 
a larger number of components for capturing the form of a particular survival function. Based 
on previous studies, it is known that there are not many studies that analysed the survival time 
estimates of HDF, the factors that influence in Indonesia by using a Bayesian Weibull mixture and 
consider model choice issues.  
The main aim of this paper is to develop and apply the Bayesian Weibull mixture 
approach to model DHF patients’ survival. This aim is addressed through the estimation of a 
two component Weibull mixture model in a simulation study and an application to a dengue 
fever dataset. The number of components does not need to be confined into two components. 
Farcomeni and Nardi (2010) stated that while extending the model to the general case is 
straightforward, in their experience the two Weibull mixture is already sufficiently flexible. 
The paper is organised as follows. In Section 2, we define the Weibull mixture model and 
Bayesian computational approach for parameter estimation. We also provide the method of 
simulation and discuss the issue of label-switching and model evaluation in Section 2. In 
Section 3, we illustrate the model using simulated datasets and a DHF dataset. The results are 
discussed further in Section 4. 
 
2.     MATERIAL AND METHODS 
2.1. MODEL FORMULATION 
In this section, we define  the Weibull mixture model for analysing survival data. We 
confine ourselves to survival times that are the difference between a nominated start time and 
a declared failure (uncensored data) or a nominated end time (censored time). Let T be a 
nonnegative random variable for a person's survival time and t be any specific value of 
interest as a realisation of the random variable T. Kleinbaum and Klein (2005) give some 
reasons for the occurrence of right censoring in survival studies, including termination of the 
study, drop outs, or loss to follow-up. For the censored observations, one could impute the 
missing survival times or assume that they are event-free. The former is often difficult, 
especially if the censoring proportion is large, and extreme imputation assumptions (such as 
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all censored cases fail right after the time of censoring) may distort inferences (Leung and 
Elashoff, 1997, Stajduhar et al., 2009). In this study, we treat all censored cases as event-free 
regardless of observation time. 
Initially, we assume that we observe survival time t on patients possibly from a 
heterogeneous population. The two parameter Weibull density function for survival time is 
given by 
𝑊 𝑡 𝛼, 𝛾 = 𝛼𝛾𝑡𝛼−1exp⁡(−𝛾𝑡𝛼) 
for   > 0 and   > 0, where  is a shape parameter and  is a scale parameter (Ibrahim et al., 
2001b). A mixture of K Weibull densities (Marin et al., 2005a) is defined by 
𝑓 𝑡|𝐾, 𝜋, 𝛼, 𝛾 =  𝜋𝑚𝑊(𝑡|𝛼𝑚 , 𝛾𝑚)
𝐾
𝑚=1
 
 
where 𝛼 = 𝛼1, 𝛼2, … , 𝛼𝐾 , 𝛾 = 𝛾1,𝛾2,… , 𝛾𝐾 are the parameters of each Weibull distribution 
and  𝑤 = 𝑤1, 𝑤2, … , 𝑤𝐾  is a vector of nonnegative weights that sum to one. 
The corresponding survival function S(t|K,,, ) and hazard function S(t|K,,, ) are as 
follows: 
𝑆 𝑡|𝐾, 𝜋, 𝛼, 𝛾 =  𝜋𝑚exp⁡(−𝛾𝑚𝑡𝑚
𝛼 )
𝐾
𝑚=1
 
𝑕 𝑡|𝐾, 𝜋, 𝛼𝛾 =
𝑓(𝑡|𝐾, 𝜋, 𝛼, 𝛾)
𝑆(𝑡|𝐾, 𝜋, 𝛼, 𝛾)
 
Let xij be the jth covariate associated with patient i, for j = 1, 2, …, p. In our application, xij 
could indicate, for example, the thrombosis’. The covariates can be included in the model as 
follows (Farcomeni and Nardi, 2010) 
log 𝛾𝑚 = 𝑥𝑖
′𝛽𝑚 = 𝜆𝑚                                                                                     (1) 
where 𝑥𝑖 = 𝑥𝑖1, 𝑥𝑖2, … , 𝑥𝑖𝑝  , 𝛾𝑚 = 𝛾1𝑚 , 𝛾2𝑚 , … , 𝛾𝑝𝑚  and 𝛽𝑚 = 𝛽1𝑚 , 𝛽2𝑚 , … , 𝛽𝑝𝑚  for i = 1, 
2,…, n and m = 1,  2, …, K. 
We now assume that we observe possibly right-censored data for n patients 𝑦 =
𝑦1, 𝑦2, … , 𝑦𝑛   where yi=(ti,δi)   and  δi   is an indicator function such that (Marin et al., 2005a) 
δi = 1, if the lifetime is uncensored, i.e., Ti = ti and δi = 0, if the lifetime is censored, i.e., Ti > 
ti. 
Thus, the likelihood function becomes: 
𝐿 𝜋, 𝛼, 𝛾|𝐾, 𝑡𝑖 , 𝛿𝑖 , 𝑥 ∝  𝑓 𝑡𝑖 𝐾, 𝑡𝑖 , 𝛿𝑖 , 𝑥 
𝛿𝑖
𝑛
𝑖=1
𝑆(𝑡𝑖|𝐾, 𝑡𝑖 , 𝛿𝑖 , 𝑥)
1−𝛿𝑖  
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Here, the incomplete information is modelled via the survivor function, which reects the 
probability that the ith patient was alive for duration greater than ti. 
In WinBUGS (Lunn et al., 2000, Ntzoufras, 2009, Spiegelhalter et al., 2002), possibly 
right censored data can be modelled using a missing data approach via the command I(., ) as 
follows 
t[i] ~ dweib(alpha[i]; gamma[i])I(cens.time[i]; ) 
 
where cens:time[i] is either zero for uncensored outcome or the ith recorded survival time for 
censored outcomes. Hence, censored survival times are assumed to be drawn from a 
truncated Weibull distribution. 
The following prior distributions were placed on the parameters  and :  
 𝜋|𝐾 ~ 𝐷𝑖𝑟𝑖𝑐𝑕𝑙𝑒𝑡 (𝜙1, 𝜙2, … , 𝜙𝐾) , 𝜙𝑚 = 𝜙, ∀𝑚 = 1, 2, … , 𝐾 
 𝛼𝑚~ 𝐺𝑎𝑚𝑚𝑎 𝑢𝛼 , 𝑣𝛼 ,𝑚 = 1, 2, … , 𝐾  
For a model without covariates, we employ the following prior for m.  
𝛾𝑚~ 𝐺𝑎𝑚𝑚𝑎 𝑢𝛾 , 𝑣𝛾 , 𝑚 = 1,2, … , 𝐾 
We choose small positive values for 𝑢𝛼 , 𝑣𝛼 , 𝑢𝛾 , 𝑣𝛾   to express vague prior knowledge 
about these parameters and we set  = 1 (Marin et al., 2005a). For a model with covariates, in 
this paper, we employed an independent normal prior on each m, so that 
𝛽𝑚 |𝐾 ~ 𝑁(0, Σ) 
and we allow m  to be diagonal with elements σj
2, j= 1, 2, …, p. We express a vaguely 
informative prior by setting σj
2
=10. The diagonal matrices were used here but this changed 
recently (Bhadra and Mallick., 2013), so one may argue that a non-diagonal variance-
covariance matrix may be more appropriate.  
 
2.2. COMPUTATION METHOD 
The model described in Section 2.1 can be fitted using MCMC sampling with latent 
values Zi to indicate component membership of the ith observation (Diebolt and Robert, 
1994, Robert and Casella, 2000). Since m = Pr(Zi = m), we can write 𝑍𝑖~𝑀 𝜋1, 𝜋2, … , 𝜋𝑘 . 
In this scheme, the Zi is  sampled by computing posterior probabilities of membership, and 
the other parameters are sampled from their full posterior distributions, conditional on the 
latent indicators. This was implemented in the WinBUGS software package (Lunn et al., 
2000). 
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Label switching, caused by non-identifiability of the mixture components, was dealt 
with post-MCMC using the reordering algorithm of Marin et al. (2005b). The algorithm 
proceeded by selecting the permutation of components at each iteration that minimised the 
vector dot product with the so-called “pivot”, a high density point from the posterior 
distribution. The MCMC output was then reordered according to each selected permutation. 
In this paper, the approximate maximum a posteriori (MAP) (i.e. The realization of 
parameters corresponding to the MCMC iterate that maximised the unnormalised posterior) 
was chosen as the pivot. 
 
2.3. MODEL EVALUATION AND COMPARISON  
 The appropriateness of the Weibull model can be checked by applying goodness of 
fit measures which summarize the discrepancy between observed values and the values 
expected under the model in question (Gupta et al., 2008). The most commonly used 
assessments of model fit are in the form of information criteria, such as the Bayesian 
Information Criterion (BIC) (Schwarz, 1978a), 
𝐵𝐼𝐶 = −2 logL 𝑡 𝜃 + 𝑘 log(𝑛), 
and Akaike Information Criterion (AIC) (Akaike, 1973), 
𝐴𝐼𝐶 =  −2 E log 𝐿 𝑡 𝜃   + 2𝑘 
For AIC,  are unknown parameters of the model and k is the number of free parameters in 
the model. The term 2k in the AIC is also a complexity measure. Both the BIC and DIC can 
be calculated from the simulated values based on MCMC results; smaller values indicate a 
more suitable model in terms of goodness of fit and short-term predictions (McGrory and 
Titterington, 2007), (Spiegelhalter et al., 2002). 
The selection of variables in regression problems has occupied the minds of many 
statisticians. Several Bayesian variable selection methods have been applied to gene 
expression and survival studies. For example, Volinsky and Raftery (2000) investigated the 
Bayesian Information Criterion (BIC) for variable selection in models for censored survival 
data and Ibrahim et al. (2008) developed Bayesian methodology and computational 
algorithms for variable subset selection in Cox proportional hazards model with missing 
covariate data. Other papers that deal with related aspects are Cai and Meyer (2011) and Gu 
et al. (2011). Cai and Meyer (2011) used conditional predictive ordinates and the DIC to 
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compare the fit of hierarchical proportional hazards regression models based on mixtures of 
B-spline distributions of various degrees. Gupta et al. (2011) presented a novel Bayesian 
method for model comparison and assessment using survival data with a cured fraction. 
In our analysis, for demonstration we compute the DIC and BIC for all possible 
subsets of variables and select these models with smallest DIC and BIC values (Burnham and 
Anderson, 2002). We also evaluate the model by applying posterior predictive checks based 
on the validation dataset. 
 
2.3. SIMULATION ALGORITHM 
 
Our interest in this study was to estimate the parameter of Bayesian Weibull mixture. 
The models developed here was the Weibull mixture model. We used the simulation 
algorithm for analyses. The probability models with five explanatory variable were used in 
simulations 
For these study, data were simulated from two component Weibull mixture models with the 
following parameter configurations: 
𝑊 𝑡|𝑘 = 2, 𝜋, 𝛼, 𝛾 = 0,5𝑊 3,1 + 0,5𝑊(2,2), 
The censoring levels20% was applied to model and a sample size of n = 200 was used for all 
experiments. The following steps were applied to carry out the simulations. 
1. Generate ti, from the respective model, for i=1,2,…,n. 
2. Generate censoring times by assuming that the largest C% survival times are right 
censored. 
3. Generate each covariate 𝑥𝑖 =  𝑥1𝑖 , 𝑥2𝑖 , … , 𝑥5𝑖  from independent standard normal 
distributions, and then set m using equation 1. For the purpose of the simulation 
study, we fixed the coefficient values relating to the covariates in each component to 
𝛽1 =  1,1,1,1,1  and 𝛽2 =  2,2,2,2,2 . 
4. Fit the model based on the data yi = (ti; _i), with 100,000 iterations, discarding 
the first 10,000 iterations as burn-in.  
5. Record posterior estimates of the model parameters, namely median and standard 
deviation. 
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3. RESULTS 
3.1. SIMULATION 
We simulated the generated data by running for Weibull mixture model with 
noninformative prior. The averaged values over the 100 simulations for median of posterior 
means and standard deviations of theWeibull mixture parameters are reported in Table 1 for 
200 sample size. The table confirms the accuracy of the parameter estimates in the 20% of 
censoring. 
Table 1. Posterior estimates of parameters  𝜶, 𝝅,𝜷𝑚   for simulation data model with 20% 
levels of censoring. 
C Parameter True value Posterior Median Posterior Standard Deviation 
20%  1, 2  3, 2  (2.967,2.122)  (0.352, 0.211)  (0.308, 0.225)(0.057, 0.024)  
11, 12  1, 2  (1.038, 1.986)(0.055, 0.069)  (0.051, 0.074)(0.007, 0.012)  
21, 22  1, 2  (0.979, 1.983)(0.049, 0.084)  (0.046, 0.072)(0.007, 0.011)  
31, 32  1, 2  (0.994, 2.007)(0.050, 0.052)  (0.046, 0.074)(0.007, 0.010)  
41, 42  1, 2  (1.024, 1.977)(0.047, 0.031)  (0.048, 0.078)(0.008, 0.012)  
51, 52  1, 2  (0.991, 1.991)(0.041, 0.061)  (0.048, 0.072)(0.007, 0.019)  
w1, w2  0.5, 0.5  (0.502, 0.498)(0.015, 0.015)  (0.048,0.048)(0.003, 0.003)  
 
3.2. APPLICATION TO DENGUE HEMORRHAGIC FEVER 
 
Here, we analyse a dataset of medical records of patients with DHF. These data were 
taken in Dr. Wahidin Sudirohusodo hospital, Makassar in 2005 - 2007. This dataset contains 
DHF patients, comprising 2091 patient. Patients with missing values for a particular DHF element 
were excluded from all analysis involving that element. The response variable used in this study is 
the length of stay, which is a long hospitalisation of patients with DHF until otherwise be 
discharged as the situation improved and within the limits of the study period, in days, with 
provisions: (a) If a patient's inpatient admission to otherwise allowed to go home because the 
situation improved in the care of Dr Wahidin Sudirohusodo hospital and within the limits of 
the study period, the survival time is categorised as not censored survival data; (b) If an 
inpatient either  exceeded the limits of research or died, o moved hospital then it is classified 
as  censored survival data. While the predictor variables were used: (a) The number of 
trombocyte (X1) is the amount of trombocyte when the patient was first declared inpatient 
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admission with a value of 1 for amount of trombocyte <50,000/μl, a value of 2 for the amount 
of trombocyte is 50000/μl-100000/ml, a value of 3 for the amount of trombocyte is 
100000/μl-150000/μl, and a value of 4 for the trombocyte amount is more than 150,000/μl. 
(b) Hematocrit levels (X2) is a hematocrit levels when the patient was first declared the 
inpatient admission. (c) Variable age (X3) is the age of the patients at admission hospital. (d) 
Variable gender (X4) with a value of 1 for female and the value 2 for male. 
We fitted Weibull mixture models to the dataset using the prior distributions 
described in Section 2. As in the simulation study, we use the WinBUGS software (see Lunn 
et al., 2009) to fit the MCMC, where for each model, 100,000 samples were collected and 
after a burning period of 10,000. Summary statistics of the dataset are given in Table 2. 
Table 2. The description of Dengue Hemorrhagic fever 
Variabel Mean Standard Deviation Median Minimum Maximum 
Survival time 3,519 2,002 3,000 1,000 15,000 
Age 3,247 0,812 3,000 1,000 6,000 
Hematocrit  38,53 6,495 39,000 3,000 78,000 
Trombocyte 85400 39849 86000 4000 150000 
 
From Table 2, we can see the average of the number of trombocyte of patients with 
DHF in Wahidin Sudirohusodo hospital Makassar was 85400, with a minimum and 
maximum amount of trombocyte were 4000/μl and 150000/μl, respectively. The smaller the 
number of trombocyte  the worse anyway disease dengue fever of a patient will be and vice 
versa. The normal amount of human trombocyte is min 100,000/μl. Thus, from Table 1 above 
there are patients whose condition is very unstable because they have a trombocyte count of 
4000/μl. Moreover, the average level of hematocrit of DHF patients was 38.53% with the 
lowest and the highest levels were 3% and 78%, respectively. Different from the trombocyte, 
for the hematocrit levels, the greater level of the patient's hematocrit, then the patients’ 
condition is likely to be more severe and vice versa. 
 An increase of hematocrit is usually preceded by a decrease in trombocyte. This 
increase reflects increasing capillary permeability and plasma leakages. It should be noted 
that the hematocrit value is affected by the replacement fluid or bleeding. Hematocrit levels 
will continue to rise if there is bleeding and will always decrease after the administration of 
fluids to patients. 
Based on the characteristics of long hospitalization of patients, subsequently we calculated the 
survival function and the hazard function. The result can be seen in Table 3. 
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Table 3 The survival probability and the hazard rate of DHF data  
t St(1) St(2) ht(1) ht(2) h(t) 
1 0.6482 0.3186 0.0692 0.0175 0.0356 
2 0.5109 0.2924 0.0280 0.0346 0.0733 
3 0.2735 0.2516 0.0101 0.0466 0.1071 
4 0.0833 0.2024 0.0023 0.0514 0.1345 
5 0.0121 0.1518 0.0003 0.0493 0.1556 
6 0.0007 0.1061 0.0000 0.0422 0.1721 
7 0.0000 0.0689 0.0000 0.0325 0.1865 
8 0.0000 0.0416 0.0000 0.0227 0.2012 
9 0.0000 0.0233 0.0000 0.0145 0.2177 
 
Table 3 shows that the probability of survival function is progressively increasing, but 
function the hazard is progressively decreasing. This means that the longer the patients stayed in the 
hospital, the lower the patients’ survival probability will be, but contrast to this,  the patient's hazards’ 
rate will be higher. The survival function gives the probability of survival of patients survive for all 
time t, for example, the probability of patients’ survive on day 4 was 0.0833, meaning that the number 
of patients who would not recover on day 4 was  8.33%, and based on the hazard function, on day 4 
patients hazard rate was 0.0023. 
Table 4. Posterior estimates of parameters (, , ) for DHF data. 
k Parameter Variable 
Posterior 
Mean 
SD 95% Credible Interval (CI) 
1 1 
 
3.104 0.157 (2.817, 3.44) 
11 trombocyte -0.344 0.120 (-0.583, -0.118) 
21 hematocrit -0.552 0.057 (-0.664, -0.439) 
31 age -0.212 0.061 (-0.334, -0.097) 
41 gender -0.201 0.083 (-0.356, -0.026) 
1 
 
0.570 0.041 (0,491 , 0,649) 
2 2 
 
1.797 0.058 (1.682, 1.919) 
12 trombocyte -0.076 0.075 (-0.223, 0.070) 
22 hematocrit -0.508 0.042 (-0.594, -0.425) 
32 age -0.150 0.043 (-0.230, -0.066) 
42 gender -0.314 0.067 (-0.442, -0.183) 
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2 
 
0.430 0.041 (0.351, 0.509) 
 
As can be seen from Table 4, the 95% credible intervals for 𝛽1, 𝛽2,𝛽3, 𝛽4 respectively 
do not include 0 in the first component. This finding is interesting, since it indicates that four 
of these variables substantially contribute to patients’ survival times, namely trombocyte, 
hematocrit, age and gender, with a negative effect on the predicted survival time. In the 
second component, the hematocrit, age and gender substantially described patients’ survival 
times and had a negative effect on the predicted survival time. Based on Table 4, the Weibull 
mixture models for the first component (W1) and the second component (W2) is 
 
𝑊 = 𝜋1𝑊1 𝑡𝑖|𝛼1,𝜆1 + 𝜋2𝑊2 𝑡𝑖|𝛼2 ,𝜆2 , 
where 𝑊1 𝑡𝑖|𝛼1 ,𝜆1 = 0.57 3,104𝑡𝑖
2,104exp 𝜆1 − exp 𝜆1 𝑡𝑖
3,104  ; 𝜆1 = −0,344𝑥𝑡𝑟𝑜𝑚𝑏𝑜𝑠𝑖𝑡 −
0,552𝑥𝑕𝑒𝑚𝑎𝑡𝑜𝑘𝑟𝑖𝑡 − 0,212𝑥𝑢𝑚𝑢𝑟 − 0,201𝑥𝑔𝑒𝑛𝑑𝑒𝑟 ; 𝑊2 𝑡𝑖|𝛼2 ,𝜆2 = 0,43 1,797𝑡𝑖
0,797𝑒𝑥𝑝 𝜆2 −
𝑒𝑥𝑝 𝜆2 𝑡𝑖
1,797  ; and 𝜆2 = −0,508𝑥𝑕𝑒𝑚𝑎𝑡𝑜𝑘𝑟𝑖𝑡 − 0,150𝑥𝑢𝑚𝑢𝑟 − 0,314𝑥𝑔𝑒𝑛𝑑𝑒𝑟  
From Table 5, we can see that the smallest value of BIC and AIC for the Weibull mixture 
model without were 6939 and 6909, respectively. Based on these, we conclude that the model 
with three components is more appropriate for this data set. 
Tabel 5. The value of BIC and AIC for DHF data 
Number of component 
(k) 
BIC AIC 
1 8288 8278 
2 7233 7213 
3 6939 6909 
 
4.  CONCLUSION AND DISCUSSION 
This paper has presented the Bayesian Weibull mixture model with MCMC 
computational methods. The case study that we considered involved DHF survival, with 
covariates given by trombocyte, hematocrit, age and gender.  
When viewed from the age, the majority of patients with this disease aged 21-30 
years. Our study also supports the work of Karyanti et al. (2014) who indicated that in those 
aged 15 years or over, DHF incidence increased.  
 The first mixture components that affect a cure DHF patient were age, gender, 
hematocrit, and trombocyte. The results show that compared to female DHF patients, male 
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patients tend to recover faster by 0.818 times. The greater the patient's hematocrit by one 
unit, the longer the recovery of the patients, which is  1,733 times, and DHF patients with 
trombocyte amount of between 4000/μl and 150 000/μl tend to recover faster by 0.708 times 
compared to those with different amount of trombocyte. 
           The second mixture components affecting a cure DHF were age, gender and 
hematocrit levels. The results show that male patients tend to heal faster by 0.371 times than 
female ones and the patient's with greater hematocrit by one unit, tends to have longer 
recovery for 1,661 times, and DHF patients with ages between 21 and 30 years tend to heal 
faster by 0.731 times than those with different ages.  
Based on two goodness-of-fit criteria, we showed that selected variables are 
substantially associated with survival in this study. Computing by using the BIC and AIC can 
estimate all possible combinations of the number of components required in determining the 
best model. For example, models that are not best in the sense of goodness of fit (based on 
these two criteria) may be interpretable with respect to their biological and medical 
implications. 
Apart from accuracy and precision criteria used for the comparison study, the 
Bayesian approach coupled with MCMC enable us to estimate the parameters of Weibull 
survival models and probabilistic inferences about the prediction of survival times. This is a 
significant advantage of the proposed Bayesian approach. Furthermore, flexibility of 
Bayesian models, ease of extension to more complicated scenarios such as a cure mixture 
model, relief of analytic calculation of likelihood function, particularly for non-tractable 
likelihood functions, and ease of coding with available packages should be considered as 
additional benefits of the proposed Bayesian approach to predict survival times. 
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